Document is current
Any future updates will be listed below
-
Authors
Proics, Emma
David, Marion
Mojibian, Majid
Speck, Madeline
Lounnas-Mourey, Nadia
Govehovitch, Adeline
Baghdadi, Wissam
Desnouveaux, Justine
Bastian, Hervé
Freschi, Laura
Privat, Geoffrey
Pouzet, Cédric
Grossi, Mauro
Heimendinger, Pierre
Abel, Tobias
Fenard, David https://orcid.org/0000-0003-0242-386X
Levings, Megan K. https://orcid.org/0000-0002-0305-5790
Meyer, François
Dumont, Céline https://orcid.org/0000-0001-7085-0180
-
Funding
Funding for this research was provided by:
Sangamo Therapeutics France
- License Information
-
More Information
Article History
Received: 7 May 2021
Revised: 23 June 2022
Accepted: 1 July 2022
First Online: 5 August 2022
Competing interests
: EP, MD, NLM, AG, WB, JD, HB, LF, GP, CP, MG, PH, TA, DF, FM, and CD are current or former full-time employees of Sangamo Therapeutics. MM, MS, and MKL received funding from Sangamo Therapeutics for the experiments.
